With years of experience in bispecific antibody (BsAb) engineering, Creative Biolabs provides custom BsAbs against pulmonary and respiratory diseases. Our experts can design and perform different BsAbs construction project according to your request, no matter for scientific project or clinical research.
The pathogenesis of pulmonary and respiratory diseases mainly includes virus infection and inflammation. There have been many monoclonal antibodies (mAbs) in clinical development for treating pulmonary and respiratory diseases, among which, a tetravalent bispecific antibody SAR156597 has been developed to treat fibrotic diseases especially idiopathic pulmonary fibrosis (IPF). Analogously, Creative Biolabs can engineer BsAbs of different formats to block proinflammatory cytokines such as interleukins, which can relieve even cure inflammation associated pulmonary and respiratory diseases.
Creative Biolabs owns advanced immunotherapy techniques, experienced scientists and skilled technicians, all of which can greatly assist you to develop BsAbs in treating pulmonary and respiratory diseases.